conjunction with ILP is an effective procedure to ameloriate OSA condition.
Objective: Compared to traditional OSA surgeries that modify skeletal and soft tissues, hypoglossal nerve stimulation alters physiology to maintain upper airway patency. To evaluate long-term stability of CN XII stimulation, AHI and nerve stimulation parameters were assessed and compared.
Method: Data were reviewed from a prospective multicenter feasibility trial of an implantable hypoglossal nerve stimulation device (Inspire, Inspire Medical) that includes both stimulation and sensing leads and a programmable stimulation generator. Polysomnographic and device outcomes were available in 24 of 36 subjects at 12-month follow-up.
Results: Six-to 12-month responder rate (a priori = 50% reduction in AHI) improved (10/24 to 12/24). AHI (baseline, 6, and 12 month) remained constant in responder (33.8, 8.8, 10 .0 events/h, P < .01) and nonresponder (48.9, 60.3, 44.1 events/hr, P < ns) groups. Three subjects were reclassified as responders and 2 as nonresponders from 6 to 12 months. Average nerve stimulation thresholds (sensation, function, and subdiscomfort) did not change from baseline to 12 months. Stimulation parameters (frequency, pulse duration, stimulation intensity but not amplitude (2.2 [0.7] vs 1.5 [0.4] Volt, P = .01)) were similar in responder groups. No additional device-related adverse events were recorded at 12 months.
Conclusion: Polysomnographic measures recorded at 6 months are maintained at 12 months following CN XII implant in the majority of patients. Average stimulation thresholds remain constant over 1 year. Results support that clinically significant improvements in AHI are maintained over the 6 to 12 month interval. The cephalometric parameters used were: SNA, SNB, PAS, PP2-PP2. Evaluation of eventual differences in pre-and postoperative data were investigated with the appropriate statistical tools. The surgical treatment proved to be effective in 8 out of 22 of the cases (36.36%), according to international criteria of normality. On the other hand, for these patients the AHI was not the best parameter to evaluate the therapeutic success.
Sleep Medicine
Results: The DM (60.18% of improvement), stage N3 (59.9% of improvement), and time of Sat O 2 <90% measured in minutes (81.81% of improvement) demonstrated they were the best instrument for characterizing the laboratorial control of desease.
Conclusion:
The surgical treatment perfomed with MMA associated with CO 2 laser MLG was effective in treating patients with moderate to severe OSAS. The improvement using the most accepted parameter by the international community (AHI below 5) was 8 out of the 22 (36.36%). The AHI was not the most accurate instrument to evaluate the control of the desease. Although MD, stage N3, and time of Sat O 2 below 90% measured in minutes demonstrated to be more appropriate indicators of surgical control of the desease. The time of Sat O 2 <90% was the best parameter in the evaluation of the surgical treatment.
Sleep Medicine Strategies to improve CPaP adherence: Zhenjiang Experience
Wei Qian, MD (presenter); James Haight; Yongming Ma; Guochang Jiang Objective: High dropout rate of CPAP is a big challenge. To improve the CPAP adherence, systemic upper airway management including subjective and objective nasal patency assessment, surgical and medical treatment to upper airway obstruction, and CPAP follow-up strategies were carried on in the present study.
Method: A prospective study. A total of 169 OSA patients (women: 34; mean age, 42.9 years) and 41 healthy subjects (women: 9; mean age, 38 years) were undertaken for polysomnography and subjective and objective nasal patency assessment. CPAP users with upper airway disorder were
